Bicycle Therapeutics PLC expected to post a loss of 68  cents a share - Earnings Preview

Bicycle Therapeutics

02/05/2022 18:01

* Bicycle Therapeutics PLC  BCYC.OQ   BCYC.O  is expected
to show
a rise in quarterly revenue when it reports  results on May 4
(estimated). 
    * The Cambridge Cambridgeshire-based  company is expected to
report  a 144.0% increase in revenue to $4.411 million from
$1.81 million a year ago, according to the mean estimate from 11
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Bicycle
Therapeutics PLC
is for a loss of 68 cents per share. For the same quarter last
year, the company reported a loss of 73 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 0.6%
in the last three months. ​
    * Wall Street's median 12-month price target for Bicycle
Therapeutics PLC is $65​, above​ its last closing price
of $23.48. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.67       -0.61      -0.63     Missed  -3.1
 Sep. 30 2021  -0.63       -0.61      -0.59     Beat    3.5
 Jun. 30 2021  -0.68       -0.73      -0.74     Missed  -1.9​
 Mar. 31 2021  -0.73       -0.71      -0.73     Missed  -3.3
 ​​Dec.        -0.54       -0.47      -0.83     Missed  -75.7
 31 2020                                                
 Sep. 30 2020  -0.51       -0.52      -0.52     Met     -0.5​
 Jun. 30 2020  -0.51       -0.48      -0.67     Missed  -40.8
 Mar. 31 2020  0.04        0.11       -0.63     Missed  -672.7
 This summary was machine generated May 2 at 17:01 GMT.  All
figures in US dollars  unless otherwise stated